DEFA14A: Beneficient Closes $9.6 Million GP Primary Capital Transaction, Issues Series B-6 Preferred Stock

Beneficient has closed a $9.6 million primary capital transaction, issuing Series B-6 Resettable Convertible Preferred Stock in exchange for a limited partner interest in an investment fund.

Summary

• Beneficient, through a subsidiary, completed a primary capital transaction involving a limited partner interest in an investment fund with a net asset value of $9.6 million.
• The company issued 965,576 shares of Series B-6 Resettable Convertible Preferred Stock to a customer in exchange for the limited partner interest.
• The Series B-6 Preferred Stock is convertible into Class A Common Stock at an initial conversion price of $0.3151 per share, subject to resets and a floor price of $0.2363 per share.
• A maximum of 40,862,294 shares of Class A Common Stock may be issued upon conversion of the Series B-6 Preferred Stock.
• The Series B-6 Preferred Stock has optional and mandatory conversion features, with mandatory conversion potentially occurring on the fifth anniversary of the original issue date, subject to certain conditions.
• The Series B-6 Preferred Stock ranks junior to other series of preferred stock and all existing and future indebtedness of the company.
• Dividends will be paid on the Series B-6 Preferred Stock on an as-converted basis when, as, and if paid on the Class A Common Stock.
• The transaction is expected to increase the collateral for the company's ExAlt loan portfolio by approximately $9.6 million.
• Upon closing of previously announced Public Stockholder Enhancement Transactions, the company believes this transaction will result in the addition of approximately $1.28 million (and an aggregate of approximately $10.46 million) of tangible book value attributable to the company's stockholders.

Sentiment

Score: 7

Explanation: The announcement is generally positive, highlighting a successful capital transaction and expected increase in tangible book value. However, the forward-looking statements and risks associated with the conversion of preferred stock temper the overall sentiment.

Positives

• The transaction provides Beneficient with a $9.6 million primary capital commitment.
• The collateral for the company's ExAlt loan portfolio is expected to increase by approximately $9.6 million.
• The company anticipates a $1.28 million increase in tangible book value attributable to stockholders upon closing of the Public Stockholder Enhancement Transactions.
• The transaction reinforces the company's ability to execute on its core liquidity and primary capital strategy.

Risks

• The conversion of the Series B-6 Preferred Stock into Class A Common Stock is subject to beneficial ownership limitations and exchange cap restrictions.
• The company's future performance and ability to meet expectations are subject to risks and uncertainties outlined in its SEC filings.
• The ultimate outcome of the Public Stockholder Enhancement Transactions, including obtaining the requisite vote of securityholders, is uncertain.

Future Outlook

The company aims to build on this momentum and pursue additional opportunities that align with its strategic vision and growth objectives, focusing on providing primary capital solutions and financing anchor commitments to general partners.

Management Comments

• Successfully completing another GP primary capital transaction reinforces our ability to execute on our core liquidity and primary capital strategy by delivering innovative financing solutions for alternative asset holders and managers, said Beneficient management.
• We believe this financing reflects our ability to drive shareholder value while supporting impactful, vertically integrated investment strategies that enhance the value of the collateral backing our ExAlt loan portfolio.
• Were excited to build on this momentum as we enter the new fiscal year and continue to pursue additional opportunities that align with our strategic vision and growth objectives.

Industry Context

Beneficient is targeting the alternative asset investment market, aiming to provide liquidity and primary capital solutions to underserved investors and general partners, addressing a potential demand of up to $330 billion for primary commitments.

Stakeholder Impact

• Shareholders may benefit from the potential increase in tangible book value and the company's strategic growth initiatives.
• The transaction provides capital to Pulse Pioneer Fund, LP, potentially benefiting its investors and the climate companies it invests in.

Next Steps

• The company will file a preliminary proxy statement and a definitive proxy statement with the SEC to seek stockholder approval for the issuance of Class A Common Stock upon conversion of the Series B-6 Preferred Stock.
• The company will continue to pursue additional opportunities that align with its strategic vision and growth objectives.

Key Dates

Keywords

Series B-6 Preferred Stock, primary capital, Beneficient, convertible preferred stock, alternative assets, ExAlt loan portfolio, GP Primary Commitment Program